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ABSTRACT
Appendectomy is a common and relatively simple procedure to remove an inﬂamed appendix, but the rate of appendectomy
varies widely across Europe. This paper investigates factors that explain differences in resource use for appendectomy.
We analysed 106 929 appendectomy patients treated in 939 hospitals in 10 European countries. In stage 1, we tested the
performance of three models in explaining variation in the (log of) cost of the inpatient stay (seven countries) or length of
stay (three countries). The ﬁrst model used only the diagnosis-related groups (DRGs) to which patients were coded, the
second model used a core set of general patient-level and appendectomy-speciﬁc variables, and the third model combined
both sets of variables. In stage two, we investigated hospital-level variation.
In classifying appendectomy patients, most DRG systems take account of complex diagnoses and comorbidities but use
different numbers of DRGs (range: 2 to 8). The capacity of DRGs and patient-level variables to explain patient-level cost
variation ranges from 34% in Spain to over 60% in England and France. All DRG systems can make better use of administrative
data such as the patient’s age, diagnoses and procedures, and all countries have outlying hospitals that could improve their
management of resources for appendectomy. Copyright © 2012 John Wiley & Sons, Ltd.
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1. INTRODUCTION
Appendectomy is a common and relatively simple procedure to remove an inﬂamed appendix. Despite the avail-
ability of advanced diagnostic technologies and well-established guidelines for its treatment (Sauerland et al.,
2006; Solomkin et al., 2010), the rate of appendectomy varies widely across Europe: in 2008, the rate per
100 000 population ranged from 76 (Poland) to 181 (Austria) (OECD Health Data, 2010).
When used for funding, diagnosis-related group (DRG) classiﬁcation systems are an important factor determin-
ing fairness and equity of payments to hospitals. If the DRG grouping fails to distinguish major factors inﬂuencing
patient costs, hospitals may avoid treating costly cases (Street et al., 2010). Using appendectomy as a case study
and exploring data from 10 countries, this paper had three key objectives: (i) to identify factors that explain
variations in resource use across patients; (ii) to assess the explanatory power of each country’s DRGs relative
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to other patient and treatment characteristics; and (iii) to assess relative hospital performance inmanaging resources
and the characteristics of hospitals that explain this performance.
2. METHODS
2.1. Data
Cases of appendectomy were identiﬁed using diagnostic and procedure codes. Eligible patients had a principal
diagnosis of appendicitis or other disease of the appendix (ICD10 codes K35-K38 or equivalent) and had under-
gone an operation on the appendix (ICD9CM code 47.0 or equivalent). We included day cases (surgery without
overnight stay), but excluded outpatients and inpatients aged less than 1 year.
Each of the 10 countries taking part in the study drew on locally available data. A tabulated summary of each
country’s data sources and description of the cross-country differences in costing methodologies are reported
elsewhere (Street et al., 2012). The analysis was based on 2008 data in all countries except France (2007) and
Poland (2009).
2.2. Regression strategy
Each country estimated three models for explaining variation in resource use across appendectomy patients: in
the ﬁrst model (MD), the independent variables are the DRGs to which patients were coded, the second model
uses a core set of patient-level variables (MP), and the third speciﬁcation includes both DRGs and patient-level
variables (MF). The dependant variable was either log of cost of the hospital stay (seven countries) or length of
stay (LoS; three countries) (Table II). Further details of the methodological approach are reported in this issue
(Street et al., 2012). In addition to the set of core patient and treatment variables, two appendectomy-speciﬁc
variables were introduced into the equations: the ﬁrst variable tests the impact of a common comorbidity
(hypertension), and the second variable tests the use of laparoscopy (done or tried but failed), which is a less
invasive procedure than open surgery (Sauerland et al., 2010). Cost analyses were run using OLS ﬁxed effects
(FESE) models. Exploratory analyses found no signiﬁcant problems with over dispersion, so LoS analyses
were run using Poisson models. Statistical signiﬁcance was assessed at the 0.1% level.
3. RESULTS
3.1. DRG structure
Countries use different numbers of DRGs to classify appendectomy patients (Table I). Poland and Sweden use only
two groups each, Spain uses six groups, and Germany uses eight.
Appendectomy DRGs are typically deﬁned by diagnosis rather than by procedure, with eight countries differ-
entiating cases with comorbidity or complications and four countries having a DRG for cases of complicated
appendicitis (e.g. perforated or gangrenous). However, only the Spanish include a laparoscopy DRG. Half the
countries modify DRGs by age, and France also adjusts by LoS and by whether the patient died. Further details
of the DRG systems for appendectomy are reported elsewhere (Quentin et al., 2012).
In Table II, each country’s DRGs are reported in ascending order of their associated reimbursement rate. The
distribution of appendectomy patients across each country’s set of DRGs is very variable. In Finland and Ireland,
over 90% patients fall into a single DRG, whereas the most populated DRG in England, Germany and Spain has
less than 60% of patients.
3.2. Descriptive statistics
The analysis included 106 929 patients treated in 939 hospitals in 10 European countries. As shown in Table II, the
number of appendectomy cases assessed by each country ranges from 1480 (Finland) to 33 394 (England), and the
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number of hospitals ranges from 5 (Finland) to 475 (Poland). Mean LoS varies from 1.9 days in Finland
to 5.1 days in Germany. It is difﬁcult to compare costs across countries because of variations in accounting
rules and cost of living, partly exempliﬁed by the observation that countries with similar LoS can have quite
different costs.
Mean patient age ranges from 24 (Ireland) to 35 (Finland), and the percentage of male patients ranges from 46%
(Germany) to 60% (Spain). In most countries, over 90% of patients are admitted as emergencies, but the ﬁgure is
lower in France (40%) and Germany (59%). This may reﬂect differences in clinical practice, such as countries
undertaking a signiﬁcantly higher proportion of planned appendectomies than elsewhere, or it could reﬂect differ-
ent coding practices.
The mean total number of diagnoses ranges from 1.0 in Finland to 2.6 in Germany, partly a reﬂection of vari-
ation in the depth of coding practice. In all countries, over 90% of patients have no recorded Charlson comorbidity.
The mean total number of procedures ranges from 1.0 (Estonia) to 4.4 (Finland). Just 1% of Estonian patients
undergo a laparoscopic appendectomy, whereas in Germany the corresponding ﬁgure is 64%.
Germany has the highest recorded rates of urinary tract infection (UTI) (almost 3%), and Spain has the highest
rate of wound infections (just over 3%). The mean rate of other surgical adverse events (such as sepsis, or acciden-
tal cut or puncture) was highest in England (0.6%).
3.3. Regression results
3.3.1. Stage 1. In the model with DRGs only (MD), the coefﬁcients for each of the DRG dummy variables are gen-
erally positive (in the cost equations) or greater than one (in the LoS equations) and signiﬁcant at the 0.1% level,
indicating that patients allocated to these DRGs have higher costs or longer stays than those in the highest volume
DRG, which is the reference group (Table III). In all countries, except Finland and Germany, appendectomy
without complication (lowest-cost category) is the reference group. Finland is an exception: appendectomy with
complication represents 90% of the cases, reﬂecting their practice of allocating all patients admitted as emergencies
to the most costly DRG (‘complicated principal diagnosis’ (DRG3)).
The DRGs are ordered in ascending order of their reimbursement rate, and the size of the coefﬁcients should
generally follow this ordering as prices are typically based on costs. There are exceptions, such as the negative
coefﬁcient for the DRG2 (appendectomy for those under 18 years of age) in the cost equations for England, and
a coefﬁcient <1 in Austria’s LoS analysis for DRG2 (under 15 years of age). In England, this suggests that these
patients are, on average, less costly to care for than those in the reference DRG despite their reimbursement being
higher. In Austria, the costs of these patients are unobserved and may not be strongly correlated with LoS.
Table I. Appendectomy DRGs: comparison across countries
DRG-split variables
Country (system)
Number of
DRGs Age
Length of
stay
Primary diagnosis
(complicated)
Complications/
co-morbidities Death
Austria (LKF) 3 x — — — —
England (HRG) 3 x — — x —
Estonia (NordDRG) 4 — — x x —
Finland (NordDRG) 3 — — x x —
France (GHM) 5 x x x x x
Germany (G-DRG) 8 x — x x —
Ireland (AR-DRG) 3 x — — x —
Poland (JGP) 2 — — x — —
Spain (AP-DRG) 6 — — x x —
Sweden (NordDRG) 2 — — x x —
Key: x, split used;—, split not used; age splits are used to differentiate children/adults (Austria, England), older people (Austria, France, Ireland)
and children (Germany). France uses LoS splits of 3, 4 and 5 days.
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The second model (MP) estimates the inﬂuence of a number of patient and episode characteristics on the cost or
LoS of appendectomy patients (Street et al., 2012). Although not always signiﬁcant, there appears to be a U-shaped
relationship between age and LoS, with younger (<11) and older (>35) age groups tending to have longer stays.
The relationship between cost and age is less clear, although patients aged between 16 and 35 years tend to have
lower costs.
Despite the differences in coding practices across countries, Table III shows that the total number of
recorded diagnoses and procedures per patient is always signiﬁcant in explaining resource use. Where signiﬁ-
cant, those who are admitted as emergencies tend to have a longer stay or higher costs. Being transferred into
hospital signiﬁcantly increases cost in England and France, but being transferred out has no impact on resource
use in any country.
Patients who die in hospital have shorter stays but higher costs, although this relationship is not always
statistically signiﬁcant (there are very few deaths). After controlling for the total number of coded
diagnoses, comorbidities (as assessed by the Charlson index and hypertension) are seldom signiﬁcant
predictors of LoS and cost. Surprisingly, English and French patients with one, non-severe, Charlson
comorbidity tend to be less costly than those with no comorbidities. This apparently counterintuitive ﬁnding
arises because of the partial correlation (in the order of r = 0.4) between this variable and that measuring
total diagnoses.
Laparoscopy is associated with shorter LoS in Ireland and Poland. In most countries, cost is signiﬁcantly
higher in patients undergoing laparoscopy, the exceptions being England (signiﬁcantly lower costs) and
Germany (non-signiﬁcant effect).
Patients who suffer post-operative wound infection are likely to have hospital stays of between 42% and
64% longer than those who do not; where statistically signiﬁcant, costs tend to be between 29% and 67%
higher too, calculated as expðb^Þ  1 (Halvorsen and Palmquist, 1980). Other adverse events tend to increase
cost but have no signiﬁcant impact on LoS. UTIs are associated with lower cost in some countries, but do
not inﬂuence LoS.
Some of the variables used in patient variable model (MP)—such as age, complications and comorbidities—
are often used in the construction of DRG systems. In the full model (MF), DRGs are introduced in addition
to the patient variables used in MP to compare their contribution to overall explanatory power of the ﬁrst
two models. In a given country, if DRGs are successfully capturing variations in resource use due to
patient-level variables, the explanatory power of MF and MD should be similar. Also, if the DRGs are even
partially capturing the impact of these patient variables, the coefﬁcients for the latter will be smaller in MF
than in MP (Street et al., 2012). This pattern is evident in most countries for total diagnoses, total
procedures and age (although the impact of age is mainly evident in the cost equations). In the DRG model
(MD), the R-squared statistic provides a proxy measure of the capacity of a DRG system to explain
variations in resource use for individual patients, whereas in our full speciﬁcation (MF), the R-squared is
driven both by DRGs and patient variables.
Comparing the R-squared values from MF with those from MP and MD, we see that the capacity of
DRGs and patient-level variables to explain cost variation among patients varies widely across countries
(Table III, Parts 1 and 2). MP explains around 60% of the variation in the cost of patients in England
and France, but less than 30% of cost variation amongst Spanish patients. In England and Sweden, the
DRGs are better than the patient-level variables at explaining variation, suggesting that country-speciﬁc
reﬁnements made to the DRG system are effective. However, because the Swedish DRG model has lower
explanatory power than the full model, Sweden could further improve its DRG system by incorporating
additional patient-level information.
In Finland, Germany and Spain,MP performs substantially better thanMD at explaining variation in cost. This
suggests that there is signiﬁcant potential to improve the DRG system in these countries by taking greater account
of the variables used inMP. For example, the Spanish DRG system takes no account of patient age, but the regres-
sion results show that young adults are signiﬁcantly less costly than the reference group (patients aged 11 to
15 years).
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In France, the explanatory power of the two partially speciﬁed models (MD and MP) is similar and a little
below the explanatory power of the fully speciﬁed model. The two sets of variables are therefore performing
the same role and can be considered virtually interchangeable.
In the LoS analyses, patient-level variables generally perform better than the DRGs in Austria, Ireland and
(to a lesser degree in) Poland. Although all three DRG systems could beneﬁt by incorporating additional patient
and treatment information, the Austrian system appears to have the greatest capacity to improve.
Figure 1. Unexplained variation in resource use across hospitals
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3.3.2. Stage 2. Figure 1 presents the unexplained variance in costs or LoS across hospitals, once the differences
in patient-level variables and DRGs are controlled for. In each country, hospitals are ranked by their deviation
from the average (national) cost of appendectomy. Hospitals on the left-hand side have lower costs than aver-
age, whereas those on the right-hand side have higher costs. We see that, even after controlling for measurable
characteristics of patients and the DRGs to which they are allocated, there are large variations in the average
cost or LoS of appendectomy cases across hospitals within each country.
All countries include hospitals with costs/LoS that are signiﬁcantly above (or signiﬁcantly below) the na-
tional average. In England, France, Sweden and, to a lesser extent, Poland, hospitals at the extremes are notably
different from the majority of hospitals in the same country.
Austria, France, Ireland, Poland, England, Germany and Spain undertook second-stage analyses of average
costs/LoS across hospitals, using estimated hospital ﬁxed effects from stage 1 as the dependent variable (Street
et al., 2012). Results are available on the EuroDRG website (http://www.eurodrg.eu). There is some evidence
of economies of scale in Austrian hospitals: higher activity volume is associated with shorter stays. In France,
the greater the number of appendectomy cases as a percentage of the hospital’s overall workload, the lower
their average cost. In England, more specialised hospitals have signiﬁcantly higher costs. None of the other
explanatory variables that we tested was found to be signiﬁcant.
4. DISCUSSION
We have analysed routinely available data in 10 countries to address three objectives: ﬁrst, to examine factors
that explain variations in costs or LoS of patients who have had an appendectomy, by exploring the patients’
demographic, diagnostic and treatment-related characteristics; second, to assess the explanatory power of
DRG systems in explaining variations in resource use relative to other patient and treatment characteristics;
and third, to assess the size and determinants of variations in hospital performance within selected countries.
The data for each country’s patients are analysed independently, but common patterns are evident.
In all countries, patient age and the number of recorded diagnoses were signiﬁcant explanatory variables of
both cost and LoS. In contrast, the comorbidities used to construct the Charlson index had limited explanatory
power. The index was originally developed to predict hospital mortality but is being used increasingly to assess
variation in costs and LoS (Cher and Lenert, 1997; Luzier et al., 2002; Guo et al., 2008; Polverejan et al.,
2003). Our analysis suggests that a simple count of diagnoses may be better than the Charlson index at
explaining resource use for appendectomy patients.
Our ﬁndings on the impact of laparoscopy on resource use were mixed. Although associated with shorter
stays in Ireland and Poland, and lower cost in England, laparoscopy is more frequently linked with signiﬁcantly
higher costs, a ﬁnding supported by other studies (Williams et al., 1996; Yau et al., 2007; Schreyögg, 2008).
But, these higher costs may be justiﬁable, as laparoscopy is associated with lower rates of wound infection
(Guller et al., 2004; Sauerland et al., 2010).
The countries in our study use diverse approaches to constructing DRGs for patients who have an
appendectomy despite it being a standardised procedure. Although almost all countries distinguish complicated
and uncomplicated appendectomies, the number of DRG categories and the basis by which patients are
categorised to one DRG or another vary widely.
Our results suggest that more is not necessarily better when constructing DRGs: Sweden, which uses two
DRGs, appears to explain variation in costs better than Germany, which uses eight DRGs. Moreover, although
we have identiﬁed signiﬁcant explanators of resource use, this is only the ﬁrst step in assessing how they might
be used to reﬁne the DRG system. For example, although age appears to be important in explaining cost, DRG
systems that incorporate extensive age adjustments—such as in Germany—do not necessarily explain cost
variation better. Further research to assess the role of age (and other signiﬁcant characteristics) in determining
resource homogenous groupings would be the next step.
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Despite appendectomy being a reasonably standardised procedure, there is considerable variation in
the average cost or LoS of patients undergoing this procedure across hospitals, both within and across
countries. Controlling for the characteristics of the appendectomy patients in each hospital and for the quality
of care, our results identiﬁed a small number of country-speciﬁc factors that may drive hospital performance.
But the wide unexplained variation may be driven by unobserved factors, including how access to the operating
theatre is managed, how discharge policies are implemented or how well staff work as a team. Our analysis
indicates which hospitals may merit further investigation to obtain intelligence on these matters and provide
examples of good or bad organisational practice.
Our study suffers the usual limitations associated with use of routine administrative data, notably its reliance
on constructing explanatory variables from the source data and measurement bias relating to how data are
recorded. A common set of variables was used to enable a standard model speciﬁcation to be applied by all
countries, but we cannot exclude the possibility that we omitted some important explanatory patient variables.
The study is also afﬂicted by cross-country differences in coding depth and differences in how particular
variables are deﬁned. This is particularly relevant for coding of the secondary diagnoses, which are also used
for identifying adverse hospital events. Differences in hospital cost-accounting methods and the way costs are
constructed may also explain observed variation in costs both across and within countries (Tan et al., 2011).
These concerns rule out analysis of pooled data across countries and underpin our decision to estimate country-
speciﬁc models. As such, the observed cross-country patterns should be interpreted cautiously.
Despite these limitations, the analysis provides valuable insights into which factors drive variations in costs
and LoS for appendectomy patients, and the ability of the different DRG systems to capture this variation. In all
10 countries examined, we ﬁnd wide variations in unexplained average hospital costs or length of stay. Our
ﬁndings suggest that there is scope for improving the DRGs in many countries, and all countries have hospitals
that could improve their productivity or their management of resources for these appendectomy patients. These
matters merit further investigation.
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